SAN DIEGO, Sept. 26, 2017 /PRNewswire/ -- AltheaDx, Inc. ("AltheaDx" or the "Company"), a commercial stage molecular diagnosticscompany specializing in the field of personalized medicine, announced today that the results from its clinical trial have been accepted for publication by the Journal of Psychiatric Research (ISSN: 0022-3956).
The publication details the results
AltheaDx is a commercial stage molecular diagnostics company which focuses on enabling physicians, managed care organizations, pharmaceutical companies and other healthcare entities to make personalized therapeutic decisions for patients. AltheaDx's IDgenetix® pharmacogenetic testing portfolio addresses some of the most prevalent clinical conditions in the United States, including cardiovascular disease, neuropsychiatric disorders and pain. AltheaDx is a CAP-accredited, CLIA-certified laboratory located in San Diego, CA. For more information, visit www.altheadx.com.
Forward Looking Statements
This press release may contain forward-looking statements regarding the business strategy of AltheaDx. These statements relate to future events and involve known and unknown risks, uncertainties and other factors that could cause actual levels of activity or performance to differ materially from those expressed or implied by these forward looking statements. These statements reflect the views of AltheaDx as of the date of this press release with respect to future events and, except as required by law, it undertakes no obligation to update or revise publicly any forward looking statements, whether as a result of new information, future events or otherwise after the date of this press release.
CONTACT: Andrew Jackson, 858-224-7264, [email protected]
View original content:http://www.prnewswire.com/news-releases/altheadx-prospective-randomized-controlled-clinical-trial-demonstrates-significant-improvements-in-the-treatment-of-depression-and-anxiety-over-standard-of-care-300525484.html
SOURCE AltheaDx, Inc.
Subscribe to our Free Newsletters!
Hashimoto's thyroiditis is an autoimmune disorder of the thyroid causing hypothyroidism. Synthetic ...
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...
Bile duct cancer occurs either within the liver or the point where the bile ducts emerge from the ...View All